Minimizing drug wastage (DW) and cost of cabazitaxel used to treat metastatic castrate-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Jiang, Di Maria
Fallah-Rad, Nazanin
Lee, Roy
Ng, Pamela
Smith, Alan D.
Hansen, Aaron Richard
Joshua, Anthony M.
Sridhar, Srikala S.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Princess Margaret Hosp, Toronto, ON, Canada
[5] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.6550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6550
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC)
    Shaya, Justin
    Randall, James Michael
    Millard, Frederick E.
    Kurzrock, Razelle
    Parsons, J. Kellogg
    Tamayo, Pablo
    McKay, Rana R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [32] Cabozantinib (C) plus docetaxel (D) and prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).
    Karzai, Fatima
    Madan, Ravi Amrit
    Theoret, Marc Robert
    Arlen, Philip M.
    Dawson, Nancy Ann
    Rosner, Inger L.
    McLeod, David G.
    Wright, John Joseph
    Cordes, Lisa M.
    Couvillon, Anna
    Chun, Guinevere
    Harold, Nancy
    Steinberg, Seth M.
    Trepel, Jane B.
    Price, Douglas K.
    Gulley, James L.
    Figg, William Douglas
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [33] Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Mar, Nataliya
    Dwabe, Sami
    Baranda, Marlon N.
    Zarrabi, Kevin K.
    Eturi, Aditya
    Gulati, Shuchi
    Parikh, Mamta
    Seyedin, Steven N.
    Kalebasty, Arash Rezazadeh
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 217 - 223
  • [34] Use of low-dose, weekly carboplatin in men with metastatic castrate-resistant prostate cancer (mCRPC).
    O'Leary-Kelly, Meghan
    Gao, Dexiang
    Weisdack, Sarah
    Lam, Elaine Tat
    Bernard, Brandon David
    Flaig, Thomas W.
    Kessler, Elizabeth Riley
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [35] Managing Side Effects of the Novel Taxane Cabazitaxel in Castrate-Resistant Prostate Cancer
    Doyle-Lindrud, Susan
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (03) : 286 - 291
  • [36] Activity of docetaxel (D) and new generation hormonotherapies (NGH) in patients with metastatic castrate-resistant prostate cancer (mCRPC) following front line cabazitaxel (C).
    Pouessel, Damien
    Terrisse, Safae Aarab
    Mouillet, Guillaume
    Breitkopf, Katharina
    Theodore, Christine
    Lobbedez, Florence Joly
    Roubaud, Guilhem
    Flechon, Aude
    Tourani, Jean-Marc
    Massard, Christophe
    Thiery-Vuillemin, Antoine
    Oudard, Stephane
    Sevin, Emmanuel
    Chevret, Sylvie
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Racial disparities in efficacy of first-line abiraterone in metastatic castrate-resistant prostate cancer (mCRPC).
    Marar, Mallika
    Long Qi
    Mamtani, Ronac
    Narayan, Vivek
    Vapiwala, Neha
    Parikh, Ravi Bharat
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [38] Potential role of rituximab in metastatic castrate-resistant prostate cancer
    Bindal, Poorva
    Jalil, Sharif A. A.
    Holle, Lisa M.
    Clement, Jessica M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (06) : 1509 - 1511
  • [39] Retreatment of Men With Metastatic Castrate-Resistant Prostate Cancer With Abiraterone
    Leibowitz-Amit, Raya
    Alimohamed, Nimira
    Vera-Badillo, Francisco E.
    Seah, Jo-An
    Templeton, Arnoud J.
    Knox, Jennifer J.
    Tannock, Ian F.
    Sridhar, Srikala S.
    Joshua, Anthony M.
    PROSTATE, 2014, 74 (14): : 1462 - 1464
  • [40] Next Generation Sequencing in metastatic castrate-resistant prostate cancer
    Adashek, Jacob J.
    Salgia, Meghan
    Pal, Sumanta K.
    UROLOGY CASE REPORTS, 2018, 19 : 60 - 62
12345